Methods and compositions related to cooperative primers and reverse transcription
US-2024182992-A1 · Jun 6, 2024 · US
US10087494B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10087494-B2 |
| Application number | US-201414569338-A |
| Country | US |
| Kind code | B2 |
| Filing date | Dec 12, 2014 |
| Priority date | Feb 26, 2009 |
| Publication date | Oct 2, 2018 |
| Grant date | Oct 2, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Nucleic acid oligomers specific for human parvovirus genomic DNA are disclosed. An assay for amplifying and detecting human parvovirus genotypes 1, 2 and 3 nucleic acid in biological specimens is disclosed. Compositions for amplifying and detecting the presence of human parvovirus genotypes 1, 2 and 3 genomic DNA in human biological specimens are disclosed.
Opening claim text (preview).
I claim: 1. An amplification oligomer combination for amplifying human parvovirus genotypes 1, 2, and 3, the oligomer combination comprising: a) at least one primer oligomer member comprising a target binding sequence that is SEQ ID NO:48 or SEQ ID NO:50; b) a first promoter-based oligomer member comprising a sequence that is SEQ ID NO:73; and c) a second promoter-based oligomer member comprising a sequence that is SEQ ID NO:78. 2. An amplification oligomer combination for amplifying human parvovirus genotypes 1, 2, and 3, the oligomer combination comprising at least one primer oligomer member and at least one promoter-based oligomer member, wherein the at least one primer oligomer member and the at least one promoter-based oligomer member hybridize to opposing strands of a human parvovirus genotype 1, 2 or 3 nucleic acid or amplicon thereof for transcription mediated amplification of the target nucleic acid or amplicon thereof between the hybridized primer and promoter-based oligomer members, wherein A) the at least one promoter-based oligomer member is a first promoter-based oligomer member that is SEQ ID NO:76 and a second promoter-based oligomer member that is SEQ ID NO:81; B) the at least one promoter-based oligomer member is selected from the group consisting of SEQ ID NOS:58, 63, 67, 68, 73, 78, 82, and combinations thereof; C) the at least one primer oligomer member is SEQ ID NO:50 and the at least one promoter-based oligomer member is a first promoter-based oligomer member that is SEQ ID NO:73 and a second promoter-based oligomer member that is SEQ ID NO:78; or D) the at least one primer oligomer member is SEQ ID NO:47 and the at least one promoter-based oligomer member is selected from the group consisting of SEQ ID NOs:73, 76, 78, 81 and combinations thereof. 3. The amplification oligomer combination of claim 1 , wherein the at least one primer oligomer member comprises the target-binding sequence that is SEQ ID NO:50. 4. The amplification oligomer combination of claim 1 , wherein the at least one primer oligomer member comprises the target-binding sequence that is SEQ ID NO:48. 5. The amplification oligomer combination of claim 1 , wherein the at least one primer oligomer member is SEQ ID NO:47. 6. The amplification oligomer combination of claim 1 , wherein the at least one primer member is selected from the group consisting of SEQ ID NO:47, SEQ ID NO:48, SEQ ID NO:49, SEQ ID NO:50 and combinations thereof. 7. A reaction mixture for performing a transcription mediated amplification reaction, wherein the reaction mixture comprises: a) an amplification oligomer combination comprising: i) at least one primer oligomer member comprising a target binding sequence that is SEQ ID NO:48 or SEQ ID NO:50; ii) a first promoter-based oligomer member comprising a sequence that is SEQ ID NO:73; and iii) a second promoter-based oligomer member comprising a sequence that is SEQ ID NO:78; and b) an enzyme comprising an activity selected from the group consisting of reverse transcriptase activity, RNA polymerase activity, and RNase H activity. 8. The reaction mixture of claim 7 , wherein the enzyme comprises reverse transcriptase activity and RNase H activity. 9. The amplification oligomer combination of claim 2 , wherein the at least one promoter-based oligomer member comprises a blocking moiety at its 3′ end.
Related publications grouped by family.
Answers are generated from the same data shown on this page.